Showing results (311-320 of 324) with videos related to
Sort By:
Pageof 33
Cancer Discovery|December 10, 2015
Loss of PTEN Promotes Resistance to T Cell-Mediated ImmunotherapyWeiyi Peng, Jie Qing Chen, Chengwen Liu, et al.The Lancet. Oncology|February 17, 2018
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysisJennifer L McQuade, Carrie R Daniel, Kenneth R Hess, et al.Cancer Discovery|June 16, 2016
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint BlockadePei-Ling Chen, Whijae Roh, Alexandre Reuben, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2018
Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical OutcomeMarie-Andrée Forget, Cara Haymaker, Kenneth R Hess, et al.The Journal of Experimental Medicine|November 11, 2022
Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltrationYifan Zhou, Yusra B Medik, Bhakti Patel, et al.Nature Communications|February 1, 2020
Comprehensive T cell repertoire characterization of non-small cell lung cancerAlexandre Reuben, Jiexin Zhang, Shin-Heng Chiou, et al.Cell|November 3, 2018
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby-Arnon, Parin Shah, Michael S Cuoco, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2022
Obesity Is Associated with Altered Tumor Metabolism in Metastatic MelanomaAndrew W Hahn, Ashley V Menk, Dayana B Rivadeneira, et al.NPJ Genomic Medicine|August 19, 2017
Genomic and immune heterogeneity are associated with differential responses to therapy in melanomaAlexandre Reuben, Christine N Spencer, Peter A Prieto, et al.Nature|January 17, 2020
B cells and tertiary lymphoid structures promote immunotherapy responseBeth A Helmink, Sangeetha M Reddy, Jianjun Gao, et al.Pageof 33